Figure 4

Effect of siRNA/ALR treatment on ROS levels expressed by glioma cells. siRNA/ALR-treated cells were incubated with different concentrations of rALR (1–100 ng/ml), subsequently loaded with DCF-DA and fluorescence intensity measured as described in Materials and Methods. Means±S.D. of six triplicate independent experiments are shown